Puente Alto

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP	Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, autoimmune disease, autoimmune disorder of the nervous system, chronic inflammatory demyelinating polyradiculoneuropathy, demyelinating disease, immune system disorder, nervous system disorder, neuromuscular disease, peripheral nervous system disorder, polyneuropathy, polyradiculoneuropathy	Enrolling by invitation	Phase 3	2026-09-30		NCT06859099
A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease	Immunoglobulin G4-Related Disease, autoimmune disease, immune system disorder	Recruiting	Phase 3	2026-09-23		NCT07190196

Clinical trials